Heron Therapeutics, Inc. (HRTX)
0.3155
-0.01
(-2.11%)
USD |
NASDAQ |
Sep 11, 16:00
0.32
0.00 (0.00%)
After-Hours: 07:43
Heron Therapeutics Market Cap : 59.77M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 59.77M |
| September 10, 2026 | 61.06M |
| September 09, 2026 | 63.09M |
| September 08, 2026 | 66.31M |
| September 04, 2026 | 65.16M |
| September 03, 2026 | 62.52M |
| September 02, 2026 | 59.28M |
| September 01, 2026 | 59.68M |
| August 31, 2026 | 60.25M |
| August 28, 2026 | 61.88M |
| August 27, 2026 | 62.92M |
| August 26, 2026 | 59.15M |
| August 25, 2026 | 61.21M |
| August 24, 2026 | 61.16M |
| August 21, 2026 | 60.29M |
| August 20, 2026 | 58.54M |
| August 19, 2026 | 59.66M |
| August 18, 2026 | 57.01M |
| August 17, 2026 | 60.63M |
| August 14, 2026 | 63.79M |
| August 13, 2026 | 63.36M |
| August 12, 2026 | 64.59M |
| August 11, 2026 | 61.35M |
| August 10, 2026 | 63.47M |
| August 07, 2026 | 92.99M |
| Date | Value |
|---|---|
| August 06, 2026 | 94.54M |
| August 05, 2026 | 95.64M |
| August 04, 2026 | 96.46M |
| August 03, 2026 | 96.44M |
| July 31, 2026 | 93.57M |
| July 30, 2026 | 93.80M |
| July 29, 2026 | 93.06M |
| July 28, 2026 | 91.63M |
| July 27, 2026 | 86.59M |
| July 24, 2026 | 85.95M |
| July 23, 2026 | 86.56M |
| July 22, 2026 | 88.18M |
| July 21, 2026 | 89.99M |
| July 20, 2026 | 90.59M |
| July 17, 2026 | 88.76M |
| July 16, 2026 | 89.76M |
| July 15, 2026 | 82.78M |
| July 14, 2026 | 81.07M |
| July 13, 2026 | 78.62M |
| July 10, 2026 | 78.15M |
| July 09, 2026 | 80.80M |
| July 08, 2026 | 84.01M |
| July 07, 2026 | 80.28M |
| July 06, 2026 | 81.82M |
| July 02, 2026 | 82.67M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 199.32M |
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
| Anika Therapeutics, Inc. | 279.17M |
| Savara, Inc. | 1.089B |
Market Cap Related Metrics
| PS Ratio | 0.3852 |
| PEG Ratio | -0.0009 |
| Price to Book Value | 10.20 |
| Price | 0.3155 |
| Earnings Yield | -60.22% |
| PEGY Ratio | -0.0009 |